Abstract LB-006: Proteogenomic characterization of human colon cancer reveals new therapeutic opportunities

Bing Zhang(Baylor Genetics), Robbert J.C. Slebos, Suhas Vasaikar(Baylor College of Medicine), Jason McDermott(University of Washington), Sara R. Savage(Baylor College of Medicine), Richard Smith(Salisbury NHS Foundation Trust), Ronald Moore(Pacific Northwest National Laboratory), Matthew Chambers(Vanderbilt University), Lisa J. Zimmerman(Unknown), Therese RW Clauss(Pacific Northwest National Laboratory), Zhiao Shi(Vanderbilt University), Matthew J. Ellis(Guardant (United States)), Vladislav Petyuk(Pacific Northwest National Laboratory), Ken S. Lau(Vanderbilt University), Osama A. Arshad(Pacific Northwest National Laboratory), Yongchao Dou(Baylor College of Medicine), Qianxing Mo(Memorial Sloan Kettering Cancer Center), D.C. Liebler(National Institute of Standards and Technology), Henry Rodriguez(Cancer Clinic), Karin Rodland(Oregon Health & Science University), Mathangi Thiagarajan(J. Craig Venter Institute), Christopher R. Kinsinger(National Institutes of Health), Tao Liu(Heze Municipal Hospital), Yun Zhang(Baylor College of Medicine), Xiaojing Wang(First Affiliated Hospital of Bengbu Medical College), Li Ding(Shenyang Agricultural University), Chen Huang(Xi'an Jiaotong University), Bo Wen(Monash University), Matthew Monroe(Pacific Northwest National Laboratory), Rui Zhao(Kunming Medical University)
Cancer Chemistry
July 1, 2019
Cited by 0


Related Papers